These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 12880696)
21. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935 [TBL] [Abstract][Full Text] [Related]
22. Multiparticulate chitosan-dispersed system for drug delivery. Shimono N; Takatori T; Ueda M; Mori M; Nakamura Y Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):620-4. PubMed ID: 12808235 [TBL] [Abstract][Full Text] [Related]
23. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553 [TBL] [Abstract][Full Text] [Related]
24. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Nafee NA; Ismail FA; Boraie NA; Mortada LM Int J Pharm; 2003 Oct; 264(1-2):1-14. PubMed ID: 12972331 [TBL] [Abstract][Full Text] [Related]
25. [Preparation of complex chitosan microcapsule and its application in controlled release of vitamin D2]. Shi X; Tan T Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):26-9. PubMed ID: 12744155 [TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of water-soluble chitosan on growth of Streptococcus mutans. Fujiwara M; Hayashi Y; Ohara N New Microbiol; 2004 Jan; 27(1):83-6. PubMed ID: 14964411 [TBL] [Abstract][Full Text] [Related]
27. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Lim ST; Forbes B; Berry DJ; Martin GP; Brown MB Int J Pharm; 2002 Jan; 231(1):73-82. PubMed ID: 11719016 [TBL] [Abstract][Full Text] [Related]
29. Development of new chitosan-cellulose multicore microparticles for controlled drug delivery. Remuñán-López C; Lorenzo-Lamosa ML; Vila-Jato JL; Alonso MJ Eur J Pharm Biopharm; 1998 Jan; 45(1):49-56. PubMed ID: 9689535 [TBL] [Abstract][Full Text] [Related]
30. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. El-Gibaly I Int J Pharm; 2002 Dec; 249(1-2):7-21. PubMed ID: 12433430 [TBL] [Abstract][Full Text] [Related]
31. Effects of low-viscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats. Morimoto K; Metsugi K; Katsumata H; Iwanaga K; Kakemi M Drug Dev Ind Pharm; 2001 Apr; 27(4):365-71. PubMed ID: 11411905 [TBL] [Abstract][Full Text] [Related]
32. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Krauland AH; Guggi D; Bernkop-Schnürch A Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914 [TBL] [Abstract][Full Text] [Related]
34. Different molecular weight chitosan microspheres: influence on drug loading and drug release. Genta I; Perugini P; Pavanetto F Drug Dev Ind Pharm; 1998 Aug; 24(8):779-84. PubMed ID: 9876526 [TBL] [Abstract][Full Text] [Related]
35. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
36. The controlled release of a drug from biodegradable chitosan gel beads. Kofuji K; Ito T; Murata Y; Kawashima S Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):579-81. PubMed ID: 10783085 [TBL] [Abstract][Full Text] [Related]
37. Protein adsorption, fibroblast activity and antibacterial properties of poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) grafted with chitosan and chitooligosaccharide after immobilized with hyaluronic acid. Hu SG; Jou CH; Yang MC Biomaterials; 2003 Jul; 24(16):2685-93. PubMed ID: 12711514 [TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. Wadhwa S; Paliwal R; Paliwal SR; Vyas SP J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753 [TBL] [Abstract][Full Text] [Related]
39. Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by Layer-by-Layer electrostatic deposition for quercetin delivery. Jeon S; Yoo CY; Park SN Colloids Surf B Biointerfaces; 2015 May; 129():7-14. PubMed ID: 25819360 [TBL] [Abstract][Full Text] [Related]